Columns
MassChallenge Launches Breakthrough Bio to Catapult International Biotech and Medtech Start-ups in the U.S. Market
2026-07-30
The Cell-Free Revolution: Scaling Exosome Therapeutics for Clinical and Commercial Success
2026-07-28
How One South Korean Hospital Built a Global Reputation Around a $5 Billion Surgical Standard
2026-06-16
Protuoso Biosciences Launches with $9.5M to Pioneer AI-Driven “Hub-and-Spoke” Biologics Development
2026-05-27
From Crisis to Blueprint: How Australian Burns Pioneer Fiona Wood Is Engineering the Future of Scarless Healing
2026-05-25
CSO Insights at ASGH 2026: Navigating AI, Investments, and the Future of Patient-Centric Biotech
2026-05-13
Public Interest Capital: George Hara’s Blueprint for Scaling Technology, Biotech, and the Middle Class
2026-04-28
The Fundraising Test: Diversification, Discipline, and Strategic Partnerships as the Durable Formula for Global Biotech Investing
2026-04-07
Evergreen VC Fund Drives Cross-sector Synergy, Connecting Global and Taiwanese Biotech Ecosystems
2025-12-10
From Laboratory to Deal-making Table: Navigating Challenges in Global Business Development and Due Diligence
2025-11-25
LATEST
Definium’s Psychedelic Anxiety Drug DT120 Moves Closer to the Mainstream With a Phase 3 Win
2026-08-14
JAMA Network Open Study Links Agent Orange and Burn Pit Exposure to Veteran Health Outcomes
2026-08-14
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia




